Skip to content
Screener

Black Diamond Therapeutics, Inc. BDTX Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$0.15Beat by $0.07
EPS estimate-$0.22

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$8.3M
EPS estimate-$0.06

FAQ

When did Black Diamond Therapeutics, Inc. report Q3 2025 earnings?
Black Diamond Therapeutics, Inc. (BDTX) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Black Diamond Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Black Diamond Therapeutics, Inc. reported eps of $-0.15 for Q3 2025.
Did Black Diamond Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.22 by $0.07.
How did Black Diamond Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 46.4% from $-0.28.
Where can I find Black Diamond Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001701541-25-000038) and the 10-Q periodic report (0001701541-25-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.